Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.

Golden JW, Josleyn M, Mucker EM, Hung CF, Loudon PT, Wu TC, Hooper JW.

PLoS One. 2012;7(7):e42353. doi: 10.1371/journal.pone.0042353. Epub 2012 Jul 31.

2.

Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model.

Golden JW, Hooper JW.

Clin Vaccine Immunol. 2010 Nov;17(11):1656-65. doi: 10.1128/CVI.00235-10. Epub 2010 Sep 15.

3.

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Hooper JW, Ferro AM, Golden JW, Silvera P, Dudek J, Alterson K, Custer M, Rivers B, Morris J, Owens G, Smith JF, Kamrud KI.

Vaccine. 2009 Dec 11;28(2):494-511. doi: 10.1016/j.vaccine.2009.09.133. Epub 2009 Oct 13.

4.

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.

Golden JW, Hooper JW.

Virology. 2008 Jul 20;377(1):19-29. doi: 10.1016/j.virol.2008.04.003. Epub 2008 May 14.

5.

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

Hooper JW, Golden JW, Ferro AM, King AD.

Vaccine. 2007 Feb 26;25(10):1814-23. Epub 2006 Nov 27.

PMID:
17240007
6.

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW.

Virol J. 2011 Sep 20;8:441. doi: 10.1186/1743-422X-8-441.

7.

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.

Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.

J Virol. 2004 May;78(9):4433-43.

8.

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.

Golden JW, Josleyn MD, Hooper JW.

Vaccine. 2008 Jun 25;26(27-28):3507-15. doi: 10.1016/j.vaccine.2008.04.017. Epub 2008 Apr 28.

PMID:
18485547
9.

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.

Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B.

Nature. 2004 Mar 11;428(6979):182-5.

PMID:
15014500
10.

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.

Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L Jr, Spano YE, Silvera PM, Moss B.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10889-94. doi: 10.1073/pnas.0804985105. Epub 2008 Aug 4.

11.

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Wyatt LS, Earl PL, Eller LA, Moss B.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4590-5. Epub 2004 Mar 11.

12.

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.

13.
14.

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24.

15.

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD.

J Virol. 2005 Jun;79(12):7845-51.

16.

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.

Hessel A, Schwendinger M, Fritz D, Coulibaly S, Holzer GW, Sabarth N, Kistner O, Wodal W, Kerschbaum A, Savidis-Dacho H, Crowe BA, Kreil TR, Barrett PN, Falkner FG.

PLoS One. 2010 Aug 16;5(8):e12217. doi: 10.1371/journal.pone.0012217.

17.

Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Hatch GJ, Graham VA, Bewley KR, Tree JA, Dennis M, Taylor I, Funnell SG, Bate SR, Steeds K, Tipton T, Bean T, Hudson L, Atkinson DJ, McLuckie G, Charlwood M, Roberts AD, Vipond J.

J Virol. 2013 Jul;87(14):7805-15. doi: 10.1128/JVI.03481-12. Epub 2013 May 8.

18.

Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.

Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL.

Vaccine. 2011 Dec 6;29(52):9684-90. doi: 10.1016/j.vaccine.2011.09.135. Epub 2011 Oct 12.

19.
20.

Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.

Marriott KA, Parkinson CV, Morefield SI, Davenport R, Nichols R, Monath TP.

Vaccine. 2008 Jan 24;26(4):581-8. Epub 2007 Nov 20.

PMID:
18077063

Supplemental Content

Support Center